Search results
Author(s):
Michael R Gold
Added:
6 years ago
Michael Gold from Medical University of South Carolina, Charleston, SA, S-ICD Registry: Subcutaneous ICD (S-ICD) Post-market approval study.
Filmed by Radcliffe Cardiology on-site at HRS 2017.
View more
Author(s):
Leah A John
,
Ahmadreza Karimianpour
,
Michael R Gold
Added:
2 years ago
The S-ICD: New Insights
Author(s):
Thomas A Turnage
,
John A Kpaeyeh
,
Michael R Gold
Added:
3 years ago
Article
Andrew Grace
Author
Foreword
Author(s):
Donald E Cutlip
Added:
3 years ago
Article
Archana Rao
Job title: Consultant Cardiologist
Author
Author(s):
Michael R Gold
Added:
3 years ago
Dr Michael R Gold (Medical University of South Carolina, Charleston, SC, US) discusses the primary results of the UNTOUCHED trial. The UNTOUCHED trial assesed the 18-month incidence of inappropriate shocks in subjects implanted with the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) for primary prevention of sudden cardiac death.
Questions:
1. What was the rationale behind the UNTOUCHED…
View more
Author(s):
G Michael Felker
,
Christopher B Granger
Added:
3 years ago
Chronic heart failure is common, disabling and deadly. It affects approximately five million people in the US and accounts for over one million hospitalizations annually.1 Despite continued improvements in heart failure therapy, mortality over five years is approximately 50%.2 This article summarizes significant recent developments in pharmacologic and device therapy for heart failure.
…
View more
Added:
1 year ago
In this interview, Dr Joanna Osmanska (University of Glasgow, UK) outlines the findings of the SUBCUT-HF I (NCT04846816)and the SQI 01-01 studies (NCT04384653).
The studies, presented at Heart Failure 2022, demonstrated that the novel subcutaneous furosemide resulted in similar efficacy in terms of diuresis and natriuresis when compared to intravenous furosemide.In addition to this the…
View more
Author(s):
Paolo Della Bella
Added:
2 years ago
In this short interview from ACC.22, Dr Paolo Della Bella (San Raffaele University-Hospital, IT) joins us to discuss the findings of the PARTITA trial (NCT01547208). The aim of this study was to determine whether the burden of ventricular tachycardia correlates with ICD shock therapies and if the timing of VT ablation affects patient prognosis.
Discussion Points:
Rationale behind this trial
…
View more